Articles tagged "Heart"

2020 American Transplant Congress
Impact of Pretransplant Malignancy on Heart and Lung Transplant Recipients
W. Kang¹, C. T. Sparrow², M. Kim¹, M. Rachid³, S. M. Soriano³
¹Internal Medicine, University of Illinois College of Medicine at Peoria, Peoria, IL, ²Department of Cardiology, University of Illinois College of Medicine at Peoria, Peoria, IL, ³Department of Pulmonology, University of Illinois College of Medicine at Peoria, Peoria, IL
*Purpose: The purpose of this study is to investigate pre-transplant malignancy (PTM) as a risk factor for worsened post-transplant prognosis in heart or lung transplant…
2020 American Transplant Congress
Pre-Liver Transplant Coronary Artery Disease Work-Up for Non-High-Risk Patients
C. Walker¹, M. Hook², T. Matyja², J. Buggs³, E. Rogers³, A. Kumar¹, N. Kemmer⁴
¹Morsani College of Medicine, University of South Florida, Tampa, FL, ²University of Tampa, Tampa, FL, ³Transplant Surgery, Tampa General Hospital, Tampa, FL, ⁴Transplant Hepatology, Tampa General Hospital, Tampa, FL
*Purpose: Coronary artery disease is a leading cause of mortality following orthotopic liver transplant, yet there is not currently a standardized protocol for pre-liver-transplant coronary…
2020 American Transplant Congress
Donor-Derived Cell-Free DNA is Not Influenced by Steroid Dosing in Heart Transplant Recipients
J. Teuteberg¹, S. Krim², M. Shullo³, S. Jimenez¹, H. Eisen⁴
¹Stanford University, Stanford, CA, ²Ochsner Medical Center, New Orleans, LA, ³West Virginia University, Morgantown, WV, ⁴Pennsylvania State University, Hershey, PA
*Purpose: Gene expression profiling (GEP) was recognized as an alternative to biopsy for rejection surveillance in the 2010 International society for Heart and Lung Transplantation…
2019 American Transplant Congress
Pre-Transplant Cardiac Work Up Does Not Predict Post-Transplant Cardiac Events at One Year among Kidney and Pancreas Transplant Recipients
S. M. Riad¹, S. Konety¹, S. Jackson², N. Raj¹, V. Vakil¹, D. Keys¹, E. Finger³, R. Spong¹
¹Medicine, University of Minnesota, Minneapolis, MN, ²Complex Care Analytics, Fairview Health Services, Minneapolis, MN, ³Surgery, University of Minnesota, Minneapolis, MN
*Purpose: Death with functioning kidney allograft due to cardiovascular etiology is among the leading causes of kidney allograft loss after transplantation. Current cardiac work up…
2019 American Transplant Congress
Absence of Antibodies in Human Neonates and Infants to Gtko/cmahko/β4galnt2ko (Triple Gene Knockout) Pig Cells: Relevance to Cardiac Xenotransplantation for Complex Congenital Heart Disease
H. Hara¹, Q. Li¹, C. A. Banks¹, T. Yamamoto¹, D. Ayares², D. C. Cleveland¹, D. K. Cooper¹
¹Surgery, University of Alabama at Birmingham, Birmingham, AL, ²Revivicor Inc., Blacksburg, VA
*Purpose: Heart transplantation (Tx) in neonates is associated with the best results of any organ Tx, but the lack of deceased human donor hearts in…
2019 American Transplant Congress
Development of Non-Human Leukocyte Antigen Antibodies in Cardiac Antibody-Mediated Rejection
S. B. See¹, B. S. Mantell², K. J. Clerkin³, B. Ray⁴, E. R. Vasilescu⁵, C. Marboe⁵, Y. Naka⁶, S. Restaino¹, P. C. Colombo³, L. J. Addonizio², M. A. Farr³, E. Zorn¹
¹Columbia Center for Translational Immunology, Columbia University, New York, NY, ²Department of Pediatrics, Columbia University, New York, NY, ³Division of Cardiology, Columbia University, New York, NY, ⁴Immucor, Georgia, GA, ⁵Department of Pathology and Cell Biology, Columbia University, New York, NY, ⁶Department of Surgery, Columbia University, New York, NY
*Purpose: Antibody-mediated rejection (AMR), mainly driven by the development of donor-specific antibodies (DSA) directed against mismatched donor class I and class II HLA, is a…
2019 American Transplant Congress
Hepatocellular Carcinoma in Fontan Liver Disease
V. Lamm¹, J. Wedd², C. Haydek², C. Obineme², A. Noll², H. Veeramachaneni², M. Muftah², R. Ford²
¹Internal Medicine, Emory, Atlanta, GA, ²Emory, Atlanta, GA
*Purpose: To add to the clinical characteristics and outcomes of hepatocellular carcinoma (HCC) in post Fontan operation patients and present, to the best of our…
2019 American Transplant Congress
Risk Stratification of Patients Undergoing Simultaneous Liver Transplantation and Cardiac Surgery
T. Diago Uso, G. D'Amico, S. Armanyous, L. Lomaglio, B. Eghtesad, M. Fujiki, F. Aucejo, K. Sasaki, N. K. Menon, M. Fares, M. Tong, K. Hashimoto, C. Miller, C. Quintini
Cleveland Clinic, Cleveland, OH
*Purpose: Evaluate risk factors and outcomes of combined liver transplantation (OLT) and cardiac surgery, including coronary artery grafting and valve replacement.*Methods: Between 1/2005 and 8/2018,…
2019 American Transplant Congress
Immunosuppressant Adherence in Adult Heart Transplant Recipients: An Analysis of Pharmacy Claims and Organ Procurement and Transplantation Network Data
W. S. Cherikh¹, A. R. Wilk¹, J. Maghirang¹, E. A. Witt², H. Kirkham³, S. Boghani², N. Hira⁴, G. Pietradoni², D. K. Klassen¹
¹United Network for Organ Sharing, Richmond, VA, ²Walgreens Co, Deerfield, IL, ³Walgreens Co, Deerfied, IL, ⁴AllianceRx Walgreens Prime, Orlando, FL
*Purpose: The current study was conducted to determine characteristics that are associated with immunosuppressant (IS) medication adherence among adult recipients of deceased donor heart transplants…
2019 American Transplant Congress
Statin Underutilization in Patients Listed for Liver Transplant
K. Mishra¹, S. Naffouj¹, S. Modi¹, C. Dagher¹, S. Gorgis¹, D. Venkat²
¹Internal Medicine, Henry Ford Hospital, Detroit, MI, ²Transplant Hepatology, Henry Ford Hospital, Detroit, MI
*Purpose: Current guidelines recommend statin use in high risk patients based on the ASCVD (atherosclerotic cardiovascular disease) score, diabetes, or LDL levels. Despite several trials…

« Previous Page
1
…
3
4
5
6
7
…
17
Next Page »